Androgenetic alopecia in a postmenopausal woman as a result of ovarian hyperthecosis

Australasian Journal of Dermatology

Volumn 44, Issue 1, 2003, Pages 62-66

  Kim, Youngjin ^a   Marjoniemi, Veli Matti ^a   Diamond, Terry ^a   Lim, Adrian ^a,b   Davis, Greg ^a   Murrell, Dedee ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

Dihydrotestosterone; Hirsutism; Insulin resistance; Virilization

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CONJUGATED ESTROGEN; CYPROTERONE ACETATE; ESTRADIOL; SPIRONOLACTONE; TESTOSTERONE;

AGED; ALOPECIA; ANDROGEN METABOLISM; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HIRSUTISM; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPERANDROGENISM; INSULIN RESISTANCE; MALE TYPE ALOPECIA; OVARIECTOMY; OVARY TUMOR; POSTMENOPAUSE; TESTOSTERONE BLOOD LEVEL; TREATMENT PLANNING; VIRILIZATION;

AGED; ALOPECIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIRSUTISM; HUMANS; OVARIAN NEOPLASMS; POSTMENOPAUSE; THECOMA;

EID: 0037325470     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.2003.00640.x     Document Type: Article

References (21)

1. Hoffmann R, Happle R. Current understanding of androgenic alopecia. Part 1: Etiopathogenesis. Eur. J. Dermatol. 2000; 10: 319-26.
2. Braithwaite SS, Erkman-Balis B, Avila TD. Postmenopausal virilization due to ovarian stromal hyperthecosis. J. Clin. Endocrinol. Metab 1978; 46: 295-300.
3. Shippel S. The ovarian theca cell: Part IV - The hyperthecosis syndrome. J. Obstet. Gynaecol. Br. Emp. 1955; 62: 321-53.
4. Maideo G, Tieu TM, Aiman J. Atypical ovarian hyperthecosis in a virilized postmenopausal woman. Am. J. Clin. Pathol. 1985; 83: 101-7.
5. Van Heyningen C, MacFarlane IA, Diver MJ, Muronda C, Tuffnel D. Virilization due to ovarian hyperthecosis in a postmenopausal woman. Gynecol. Endocrinol. 1988; 2: 331-8.
6. Leedman PJ, Bierre AR, Martin FIR. Virilizing nodular ovarian stromal hyperthecosis, diabetes mellitus and insulin resistance in a postmenopausal woman. Case report. Br. J. Obstet. Gynaecol. 1989; 96: 1095-8.
7. Goldman JM, Kapadia LJ. Virilization in a postmenopausal woman due to ovarian stromal hyperthecosis. Postgrad. Med. J. 1991; 67: 304-6.
8. Koroscil TM, Harter SB, Ouweleen J, Blauer KL. Use of a gonadotropin-releasing hormone agonist in the evaluation of postmenopausal virilization due to ovarian hyperthecosis. A case report. J. Reprod. Med. 1996; 41: 259-62.
9. Manieri C, Di Bisceglie C, Fornengo R, Grosso T, Zumpano E, Calvo F, Berardengo E, Vlante M, Papotti M. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis. J. Endocrinol. Invest. 1998; 21: 128-32.
10. Russell P, Farnsworth A. Surgical anatomy. In: Russell P, Farnsworth A (eds). Surgical Pathology of the Ovaries, 2nd edn. New York: Churchill Livingstone, 1997; 7-9.
11. Russell P, Farnsworth A. Stromal hyperplasia and hyperthecosis. In: Russell P, Farnsworth A (eds). Surgical Pathology of the Ovaries, 2nd edn. New York: Churchill Livingstone, 1997; 137-43.
12. Boss JH, Scully RE, Wegner KH, Cohen RB. Structural variations in the adults ovary - Clinical significance. Obstet. Gynecol. 1965; 25: 747-64.
13. Aiman J, Edman CD, Worley RJ, Vellios F, MacDonald PC. Androgen and estrogen formation in women with ovarian hyperthecosis. Obstet. Gynecol. 1978; 51: 1-9.
14. Agoratos T, Argyriadis N, Fraggidis G, Vakiani A, Zournatzi V, Bontis J. Postmenopausal virilization due to ovarian hyperthecosis. Arch. Gynecol. Obstet. 1995; 256: 209-11.
15. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC. A prospective study of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin. Endocrinol. 1994; 41: 231-5.
16. Cumming DC. Menarche, menses, and menopause: A brief review. Cleve. Clin. J. Med. 1990; 57: 169-75.
17. Pascale M, Pugeat M, Roberts M, Rousset H, Dechaud H, Dutrieux-Berger N, Tourniaire J. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clin. Endocrinol. 1994; 41: 571-6.
18. deKoning J, van Dieten JAMJ, van Rees GP. Refractoriness of the pituitary gland after continuous exposure to luteinizing hormone-releasing hormone. J. Endocrinol. 1978; 79: 311-18.
19. Nagamani M, Dinh TV, Kelver ME. Hyperinsulinemia in hyperthecosis of the ovaries. Am. J. Obstet. Ggynecol. 1986; 154: 384-9.
20. Nagamani M, Hannigan EV, Dinh TV, Stuart CA. Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer. J. Clin. Endocrinol. Metab. 1998; 67: 144-8.
21. Cumming DC. Androgenesis and androdynamics in normal women. Cleve. Clin. J. Med. 1990; 57: 161-6.